• Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Given Average Rating of "Buy" by Brokerages

    Source: Buzz FX / 24 Nov 2024 03:46:08   America/Chicago


    Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Given Average Rating of "Buy" by Brokerages Written by MarketBeat November 24, 2024 Share Link copied to clipboard. Aclaris Therapeutics, Inc. ( NASDAQ:ACRS - Get Free Report ) has earned an average
    Read more...
Share on,